Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer
Egile Nagusiak: | , , , , , , , , , , , , , , , , |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
BMJ Publishing Group
2022-06-01
|
Saila: | Journal for ImmunoTherapy of Cancer |
Sarrera elektronikoa: | https://jitc.bmj.com/content/10/6/e004703.full |